Supreme Court seeks 16% margin cap on medicine prices
By United One News · AI-generated summary of 4 outlets' reporting
Published · Updated
AI-generated summary of the coverage listed below:
The Supreme Court of India is demanding a 16% cap on medicine margins after finding large price gaps harming patients.
- The court described the price disparity between retail and procurement costs as “carnage, plain and simple.”
- It noted that opaque pricing harms ordinary patients while private hospitals profit from the difference.
- A bench of Justices Vikram Nath and Sandeep Mehta is reviewing petitions for stricter price controls.
Covered by 4 outlets across the spectrum: 25% left, 50% center, 25% right.
How each side framed it
Supreme Court questions steep mark-ups on cancer drugs, calls pricing disparity ‘carnage’
'This is carnage': SC questions huge gap in medicine prices, seeks 16% margin cap
"This Is Carnage": SC Flags 10-Times Markup On Cancer Drugs
Timeline
First reported by Deccan Herald on ; 4 articles from 4 outlets so far.
Who is covering this story
- Left-leaning (1): The Hindu
- Center (2): Deccan Herald, The Hindu BusinessLine
- Right-leaning (1): Deccan Chronicle
Sources
- 'This is carnage': SC questions huge gap in medicine prices, seeks 16% margin cap — Deccan Herald (center) ·
- SC questions steep mark-ups on cancer drugs, calls pricing disparity ‘carnage’ — The Hindu BusinessLine (center, AI-estimated) ·
- "This Is Carnage": SC Flags 10-Times Markup On Cancer Drugs — Deccan Chronicle (right-leaning) ·
- Supreme Court questions steep mark-ups on cancer drugs, calls pricing disparity ‘carnage’ — The Hindu (left-leaning) ·